Item:Q21993: Difference between revisions
Added [en] aliases: (5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol, 1alpha,25-dihydroxycholecalciferol, 1alpha,25(OH)2D3, 1-alpha-25-Dihydroxyvitamin D3, 1,25-Dihydroxyvitamin D3, Ro 21-5535, 1a,25-Dihydroxyvitamin D3, Silkis, 1,25-Dihydroxyvitamin D, 1,25 Dihydroxycholecalciferol, (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol, 1a,25-(OH)2D3, Toptriol, 1-al... |
Added link to [en]: Calcitriol |
||
(19 intermediate revisions by the same user not shown) | |||
Property / instance of | |||
Property / instance of: type of chemical entity / rank | |||
Normal rank | |||
Property / subclass of | |||
Property / subclass of: D3 vitamins / rank | |||
Normal rank | |||
Property / subclass of | |||
Property / subclass of: 9,10-secocholestane steroid / rank | |||
Normal rank | |||
Property / part of | |||
Property / part of: calcitriol binding / rank | |||
Normal rank | |||
Property / part of: calcitriol binding / qualifier | |||
Property / part of | |||
Property / part of: calcitriol biosynthetic process from calciol / rank | |||
Normal rank | |||
Property / part of: calcitriol biosynthetic process from calciol / qualifier | |||
Property / part of | |||
Property / part of: calcidiol 1-monooxygenase activity / rank | |||
Normal rank | |||
Property / part of | |||
Property / part of: 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity / rank | |||
Normal rank | |||
Property / has use | |||
Property / has use: medication / rank | |||
Normal rank | |||
Property / chemical structure | |||
Property / chemical structure: Calcitriol2.svg / rank | |||
Normal rank | |||
Property / chemical formula | |||
C₂₇H₄₄O₃ | |||
Property / chemical formula: C₂₇H₄₄O₃ / rank | |||
Normal rank | |||
Property / medical condition treated | |||
Property / medical condition treated: acropustulosis / rank | |||
Normal rank | |||
Property / medical condition treated | |||
Property / medical condition treated: hyperparathyroidism / rank | |||
Normal rank | |||
Property / medical condition treated | |||
Property / medical condition treated: rickets / rank | |||
Normal rank | |||
Property / subject has role | |||
Property / subject has role: antipsoriatic / rank | |||
Normal rank | |||
Property / subject has role | |||
Property / subject has role: bone density conservation agents / rank | |||
Normal rank | |||
Property / subject has role | |||
Property / subject has role: vitamin / rank | |||
Normal rank | |||
Property / subject has role | |||
Property / subject has role: calcium channel agonists / rank | |||
Normal rank | |||
Property / subject has role | |||
Property / subject has role: primary metabolite / rank | |||
Normal rank | |||
Property / has part(s) | |||
Property / has part(s): carbon / rank | |||
Normal rank | |||
links / en / name | links / en / name | ||